TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.30$ -1.6% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 27 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CELU
Line item 2018 2019 2020 2021 2022 2023 2024 2025
18 21 14 21 18 23 54 27
6.6 6.3 4.9 9.7 20 16 15 6.4
11 15 9.3 12 -1.7 6.8 39 20
29 46 53 88 78 30 17 15
41 31 71 66 51 59 51
0.0 279 161 121 24 99 78 81
0.0 -264 -152 -109 -26 -76 -38 -61
0.0 3.7 2.4 3.2 3.2 3.0 6.3 6.8
0.0 -268 -213 -100 14 -196 -58 -92
21 -56 -4.7 0.0 0.0 0.0 0.0
0.0 -212 -208 -100 14 -196 -58 -92
0.0 -71 -202 -88 -139 -44 -78

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?